COMMUNIQUÉS West-GlobeNewswire

Inovalon Holdings, Inc. Announces Date of Its 2018 Annual Meeting of Stockholders
26/03/2018
BOWIE, Md., March 26, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
Bavarian Nordic A/S - Notice Convening Ordinary General Meeting
26/03/2018
COPENHAGEN, Denmark, 26 March, 2018 - Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic A/S are hereby convened to the annual General Meeting to be held on Tuesday, April 17 [...]
Precipio Enters India Liquid Biopsy Market with Adoption by Leading Laboratory
26/03/2018
NEW HAVEN, Conn., March 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostic company Precipio, Inc. ( NASDAQ:PRPO ) , today announced a laboratory services agreement with CORE Diagnostics to offer ICE COLD-PCR ™ (ICP) [...]
Transactions under Novozymes’ stock buyback program
26/03/2018
Please read the full announcement in the attached PDF 2018_10_Stock_Buybackprogram_EN
Evoke Announces Agreement with Mallinckrodt to Amend Milestone Payments
26/03/2018
SOLANA BEACH, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has [...]
Dentsply Sirona Announces Acquisition of Technology Solutions Provider OraMetrix
26/03/2018
YORK, Pa., March 26, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced the signing of a definitive agreement to acquire OraMetrix, a [...]
Strongbridge Biopharma plc to Host Investor and Analyst Day on April 5, 2018
26/03/2018
DUBLIN, Ireland and TREVOSE, Pa., March 26, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Cancer Genetics to Host Fourth Quarter and Full Year 2017 Financial Results
26/03/2018
RUTHERFORD, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that it will [...]
TG Therapeutics, Inc. to Present at the Needham 17th Annual Healthcare Conference
26/03/2018
NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ) today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will present at the Needham 17 th [...]
PotNetwork Holding, Inc Creates New Market Opportunity for Domestic and International Pet Retailers with the Launch of Diamond CBD’s “MediPets” Product Line
26/03/2018
FT LAUDERDALE, Fla., March 26, 2018 (GLOBE NEWSWIRE) -- VIA OTC PR Wire -- PotNetwork Holding, Inc (OTC Pink:POTN) On Friday, March 23rd, PotNetwork Holding Inc.’s wholly owned subsidiary, Diamond CBD Inc., closed out a [...]
Sol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results
26/03/2018
NESS ZIONA, Israel, March 26, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL ) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018
26/03/2018
Geneva, Switzerland and Boston, MA - March 26, 2018 - ObsEva SA (NASDAQ: OBSV ), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Athenex, Inc. Announces Fourth Quarter and Full-Year 2017 Results
26/03/2018
Fourth Quarter 2017 and Recent Business Highlights: Met enrollment targets and received positive feedback from the US FDA for Oraxol Phase III Clinical Trial in metastatic breast cancer Announced strategic partnership [...]
Akcea Convenes First FCS Global Connection Summit
26/03/2018
CAMBRIDGE, Mass., March 26, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat people with serious [...]
Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago
26/03/2018
THOROFARE, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, has entered into a three- [...]
Apricus Biosciences Announces Scheduling of Vitaros™ End-of-Review Meeting with FDA
26/03/2018
SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that its end-of-review [...]
Axsome Therapeutics to Present at H.C. Wainwright Annual Global Life Sciences Conference
26/03/2018
NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders [...]
Zynerba Pharmaceuticals Announces Publication of Preclinical Data in Neuropsychopharmacology Demonstrating Effect of Cannabidiol Gel Treatment in Reduction of Relapse in an Addiction Model
26/03/2018
DEVON, Pa., March 26, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]
Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults With Type 1 Diabetes
26/03/2018
New Drug Application Submitted to U.S. Food and Drug Administration Marketing Authorization Application Submitted to European Medicines Agency THE WOODLANDS, Texas, March 26, 2018 (GLOBE NEWSWIRE) -- Lexicon [...]

Pages